83 related articles for article (PubMed ID: 12735108)
1. Gene expression profiles associated with inflammation, fibrosis, and cholestasis in mouse liver after griseofulvin.
Gant TW; Baus PR; Clothier B; Riley J; Davies R; Judah DJ; Edwards RE; George E; Greaves P; Smith AG
EHP Toxicogenomics; 2003 Jan; 111(1T):37-43. PubMed ID: 12735108
[TBL] [Abstract][Full Text] [Related]
2. Hepatic gene expression in protoporphyic Fech mice is associated with cholestatic injury but not a marked depletion of the heme regulatory pool.
Davies R; Schuurman A; Barker CR; Clothier B; Chernova T; Higginson FM; Judah DJ; Dinsdale D; Edwards RE; Greaves P; Gant TW; Smith AG
Am J Pathol; 2005 Apr; 166(4):1041-53. PubMed ID: 15793285
[TBL] [Abstract][Full Text] [Related]
3. Bile secretion and liver microsomal mixed function oxidase system in mice with griseofulvin-induced hepatic protoporphyria.
Cantoni L; Di Padova C; Rovagnati P; Ruggieri R; Dal Fiume D; Tritapepe R
Toxicology; 1983 May; 27(1):27-39. PubMed ID: 6679936
[TBL] [Abstract][Full Text] [Related]
4. Importance of bile acid structure in amelioration of griseofulvin-induced murine protoporphyric hepatopathy.
Berenson MM; Welch V; Garcia-Marin JJ
J Lab Clin Med; 1991 Jul; 118(1):89-98. PubMed ID: 2066649
[TBL] [Abstract][Full Text] [Related]
5. Hepatic damage and oxidative stress induced by Griseofulvin in mice.
Martinez Mdel C; Afonso SG; Meiss RP; Buzaleh AM; Batlle A
Cell Mol Biol (Noisy-le-grand); 2009 Jul; 55(2):127-39. PubMed ID: 19656461
[TBL] [Abstract][Full Text] [Related]
6. Effect of ursodeoxycholic acid on experimental hepatic porphyria induced by griseofulvin.
Choi SW; Han JH; Lim KT; Cho HM; Chung KW; Sun HS; Park DH; Kim BS; Seo EJ
J Korean Med Sci; 1991 Jun; 6(2):146-56. PubMed ID: 1751019
[TBL] [Abstract][Full Text] [Related]
7. Reversibility of hepatic fibrosis in experimentally induced cholestasis in rat.
Abdel-Aziz G; Lebeau G; Rescan PY; Clément B; Rissel M; Deugnier Y; Campion JP; Guillouzo A
Am J Pathol; 1990 Dec; 137(6):1333-42. PubMed ID: 2260623
[TBL] [Abstract][Full Text] [Related]
8. Measurement of liver collagen synthesis by heavy water labeling: effects of profibrotic toxicants and antifibrotic interventions.
Gardner JL; Turner SM; Bautista A; Lindwall G; Awada M; Hellerstein MK
Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1695-705. PubMed ID: 17347453
[TBL] [Abstract][Full Text] [Related]
9. Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury.
Stedman CA; Liddle C; Coulter SA; Sonoda J; Alvarez JG; Moore DD; Evans RM; Downes M
Proc Natl Acad Sci U S A; 2005 Feb; 102(6):2063-8. PubMed ID: 15684063
[TBL] [Abstract][Full Text] [Related]
10. Griseofulvin-induced cholestasis in Swiss albino mice.
Yokoo H; Craig RM; Harwood TR; Cochrane C
Gastroenterology; 1979 Nov; 77(5):1082-7. PubMed ID: 488635
[TBL] [Abstract][Full Text] [Related]
11. A metabolomic perspective of griseofulvin-induced liver injury in mice.
Liu K; Yan J; Sachar M; Zhang X; Guan M; Xie W; Ma X
Biochem Pharmacol; 2015 Dec; 98(3):493-501. PubMed ID: 26343413
[TBL] [Abstract][Full Text] [Related]
12. Early growth response factor-1 is critical for cholestatic liver injury.
Kim ND; Moon JO; Slitt AL; Copple BL
Toxicol Sci; 2006 Apr; 90(2):586-95. PubMed ID: 16423862
[TBL] [Abstract][Full Text] [Related]
13. Effects of bile duct ligation on hepatic expression of female-specific CYP2C12 in male and female rats.
Chen J; Robertson G; Field J; Liddle C; Farrell GC
Hepatology; 1998 Sep; 28(3):624-30. PubMed ID: 9731550
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor ligands in murine models for erythropoietic protoporphyria: potential novel players in the progression of liver injury.
Berasain C; Sampedro A; Mauleón I; Goñi S; Latasa MU; Matscheko N; García-Bravo M; Unzu C; Corrales FJ; Enríquez de Salamanca R; Prieto J; Avila MA; Fontanellas A
Cell Mol Biol (Noisy-le-grand); 2009 Feb; 55(1):29-37. PubMed ID: 19267999
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of hepatic transporters in the absence of tumor necrosis factor-alpha, interleukin-1beta, interleukin-6, and nuclear factor-kappaB in two models of cholestasis.
Lickteig AJ; Slitt AL; Arkan MC; Karin M; Cherrington NJ
Drug Metab Dispos; 2007 Mar; 35(3):402-9. PubMed ID: 17151194
[TBL] [Abstract][Full Text] [Related]
16. Effect of cholestasis produced by bile duct ligation on hepatic heme and hemoprotein metabolism in rats.
Schacter BA; Joseph E; Firneisz G
Gastroenterology; 1983 Feb; 84(2):227-35. PubMed ID: 6401253
[TBL] [Abstract][Full Text] [Related]
17. Hepatic gene expression and lipid homeostasis in C57BL/6 mice exposed to hydrazine or acetylhydrazine.
Richards VE; Chau B; White MR; McQueen CA
Toxicol Sci; 2004 Nov; 82(1):318-32. PubMed ID: 15282401
[TBL] [Abstract][Full Text] [Related]
18. A dual reporter gene transgenic mouse demonstrates heterogeneity in hepatic fibrogenic cell populations.
Magness ST; Bataller R; Yang L; Brenner DA
Hepatology; 2004 Nov; 40(5):1151-9. PubMed ID: 15389867
[TBL] [Abstract][Full Text] [Related]
19. Biliary intervention aggravates cholestatic liver injury, and induces hepatic inflammation, proliferation and fibrogenesis in BDL mice.
Wen YA; Liu D; Zhou QY; Huang SF; Luo P; Xiang Y; Sun S; Luo D; Dong YF; Zhang LP
Exp Toxicol Pathol; 2011 Mar; 63(3):277-84. PubMed ID: 20149605
[TBL] [Abstract][Full Text] [Related]
20. Deletion of clock gene Per2 exacerbates cholestatic liver injury and fibrosis in mice.
Chen P; Kakan X; Wang S; Dong W; Jia A; Cai C; Zhang J
Exp Toxicol Pathol; 2013 May; 65(4):427-32. PubMed ID: 22261359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]